Loopbaan van Raphael J. Mannino
Eerdere bekende functies van Raphael J. Mannino
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2015 | 11-08-2022 |
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | 01-01-1990 | 01-08-2015 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Directeur/Bestuurslid | 01-01-2000 | 01-01-2007 |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2001 | 01-01-2009 | |
| Oprichter | 01-01-1995 | 01-01-2009 | |
| Albany Medical College | Corporate Officer/Principal | 01-01-1980 | 01-01-1990 |
| New Jersey Medical School | Corporate Officer/Principal | 01-01-1980 | 01-01-1980 |
BioVest International, Inc.
 BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Directeur/Bestuurslid | 01-06-2003 | - |
| Independent Dir/Board Member | 01-06-2003 | - |
Opleiding van Raphael J. Mannino
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
- Beurs
- Insiders
- Raphael J. Mannino
- Ervaring
